Investors FAQs
What are Syngenta’s corporate headquarters address and telephone number?
The global headquarter of Syngenta is located in Basel, Switzerland:
Syngenta International AG
P.O. Box
CH-4002 Basel
Switzerland
Phone: +41 61 323 11 11
What is Syngenta’s vision & main areas of activity?
Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
In 2009, our sales were approximately $11.0 billion.
Click here to learn more about us.
How often is your Web site updated?
The Investor and Media Centers are updated frequently. Our Stock Information is updated several times per hour. Most of the general information on the site will not be updated as often because it is unlikely to become dated.
What is Syngenta’s Stock Ticker and what exchange is Syngenta traded on?
Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT).
| Syngenta AG | ||
|---|---|---|
| Exchange: SIX Swiss ( Zurich ) | Currency: CHF | Symbol: SYNN |
| Syngenta AG (ADR) | ||
|---|---|---|
| Exchange: NYSE ( New York ) | Currency: USD | Symbol: SYT |
How do I get printed copies of Syngenta’s financial information?
You can order printed copies of the complete audited financial statements by contacting us here:
By e-mail
Or write us to the following address:
Syngenta International AG
Investor Relations
Schwarzwaldallee 215
P.O. Box
CH-4002 Basel
Switzerland
When is the company's year end?
December 31st
Who is your independent auditor?
Ernst & Young was appointed as Group auditor at the Annual General Meeting in April 2002. The appointment of the auditor is for one year, renewable annually.
What currency are your financial statements prepared?
Our consolidated financial results are prepared in US dollars in accordance with International Financial Reporting Standards (“IFRS”).
When does the next Annual General Meeting (“AGM”) take place?
The next AGM will take place on April 19, 2011.
Click here for more information on our Calendar of Events.
Who are Syngenta's key management members?
at January 1, 2010
| Name | Age | Nationality | Function | Entry |
|---|---|---|---|---|
| Michael Mack | 49 | American | Chief Executive Officer | 2005 |
| Alejandro Aruffo | 50 | American/ Italian | Head of Research & Development | 2008 |
| John Atkin | 56 | British | Chief Operating Officer - Crop Protection | 2000 |
| Robert Berendes | 44 | German | Head of Business Development | 2007 |
| Christoph Mäder | 50 | Swiss | Head of Legal & Taxes and Company Secretary | 2000 |
| Mark Peacock | 48 | British | Head of Global Operations | 2007 |
| Davor Pisk | 51 | British | Chief Operating Officer - Seeds | 2008 |
| John Ramsay | 52 | British | Chief Financial Officer | 2007 |
Click here to learn more about our Executive Committee.
How many employees does Syngenta have?
To meet the needs of individual markets, we have a global total of more than 25,000 people in over 90 countries.
What are your key financial targets?
In the second half of 2010 we expect positive volume momentum to continue. As we approach the main season in Latin America, we are assuming that the current favorable fundamentals will support further growth in our business there. This, coupled with careful control of costs and increasing profitability in Seeds, should allow us to achieve full year operating income around last year’s level. We will also target a return on invested capital exceeding 20%.
In Seeds, we remain on track to achieve our EBITDA margin target of 15% in 2011 (2009 Seeds EBITDA margin: 9.5%).
As part of our objective to maintain our single A credit rating, we will continue to target a gearing** ratio between 25 and 35 per cent.
** net debt/shareholder’s equity
What levels of cash do you return to your shareholders?
We aim to maintain balanced capital efficiency through investment to meet the requirements of our growing business, make selective acquisitions and at the same time return cash to shareholders.
The total cash return for the period 2004-2009 was over $4.0 billion.
In 2010, a dividend of CHF 6.00 per share was paid on 27 April 2010 to shareholders of record on 22 April 2010. We also plan a share repurchase, representing a total cash return in 2010 of $750 million.
What do you pay to your shareholders in the form of dividends?
The 2010 dividend was CHF 6.00 and was paid in cash on 27 April 2010 based on an ex-dividend date of 22 April 2010..
The 2009 dividend was CHF 6.00 and was paid in cash on 24 April 2009 based on an ex-dividend date of 24 April 2009.
What is your Weighted Average Cost of Capital (“WACC”)?
Our WACC is estimated at approximately 8%.
What are your debt ratings?
| S&P: | A |
| Moody's: | A2 |
Both rating agencies reviewed Syngenta in the first half of 2010 and reconfirmed their ratings based on our strong business profile, conservative financial profile, sustained strong cash generation and financial strategy.
Where can I obtain more information?
You can reach our Investor Relations team via email or on the following numbers:
| Jennifer Gough | Switzerland | Direct line | +41 (0)61 323 5059 |
| USA | Alternate | +1 (202) 737 6521 | |
| John Hudson | Switzerland | Direct line | +41 (0)61 323 6793 |
| USA | Alternate | +1 (202) 737 6520 |
This site contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.
